UnitedHealth Group has called in its CEO to deal with a Medicare Advantage program that’s crunching margins.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Honeywell may just be the next conglomerate to split into various pieces. At least if Elliott Investment Management has its way.
A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Elon Musk’s Boring Company has held talks with the Federal Railroad Administration about building a multi-billion dollar Amtrak tunnel.
Nestlé and Formula 1 announced on Monday that starting with the upcoming 2025 season KitKat will be the sport’s “official chocolate bar.”
Dissapointing results for two mid-stage trials strikes a blow in Abbvie’s expensive pipeline-via-M&A strategy.
Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.
The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Ferrari reported improved sales and earnings in the third quarter, extending its streak of outperforming other luxury auto companies.
A recapitalization plan would end News Corp’s dual-class share structure, which gives the Murdoch family outsized control of the company.
FERC kiboshed a bid to increase the amount of power that a nuclear plant in Pennsylvania is allowed to supply to one of Amazon’s data centers.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
Future battlefields will be shaped by AI weapons that defense firms and Big Tech are vying to build for the military. Guardrails are lagging.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.